Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 231: Which of the following statements is true regarding the Maternal Mortality Rate (MMR)?

A. MMR is calculated as a ratio.
B. The numerator includes deaths related to pregnancy complications up to 42 days after pregnancy ends. (Correct Answer)
C. The denominator includes stillbirths and abortions.
D. MMR is expressed as a rate per 1000 live births.

Explanation: This question tests your understanding of maternal health indicators, a high-yield area in Epidemiology. ### **Explanation of the Correct Option** **Option B is correct.** According to the WHO, a maternal death is defined as the death of a woman while pregnant or within **42 days** of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management (but not from accidental or incidental causes). ### **Why Other Options are Incorrect** * **Option A:** Despite its name, Maternal Mortality "Rate" is technically a **Ratio**. In a true rate, the numerator is a subset of the denominator. Here, the numerator is maternal deaths, while the denominator is live births (two different entities). * **Option C:** The denominator for MMR is **Total Live Births** only. It specifically excludes stillbirths, abortions, and fetal deaths to ensure a standardized measure of obstetric risk. * **Option D:** MMR is expressed per **100,000 live births**. Most other mortality indicators (like IMR or CBR) use 1,000 as the multiplier, making this a common trap for students. ### **High-Yield Clinical Pearls for NEET-PG** * **Maternal Mortality Rate:** Uses "Number of married women (15-49 years)" as the denominator. It measures the risk of death per woman of reproductive age. * **Maternal Mortality Ratio:** Uses "Live Births" as the denominator. It measures the obstetric risk per pregnancy. * **Late Maternal Death:** Death occurring between 42 days and 1 year after delivery. * **Most Common Cause of Maternal Mortality:** In India, **Obstetric Hemorrhage** (specifically Postpartum Hemorrhage) remains the leading cause. * **SDG Target:** The Sustainable Development Goal (3.1) aims to reduce the global MMR to less than **70 per 100,000** live births by 2030.

Question 232: Which of the following are used to evaluate a screening test?

A. Sensitivity
B. Specificity
C. Predictive value
D. All the above (Correct Answer)

Explanation: To evaluate the performance and clinical utility of a screening test, we use several statistical measures that assess its accuracy and reliability. ### **Explanation** The correct answer is **D (All the above)** because evaluating a screening test requires looking at two distinct dimensions: 1. **Validity (Accuracy):** This is the ability of a test to distinguish between those who have the disease and those who do not. It is measured by: * **Sensitivity (Option A):** The ability of the test to correctly identify those with the disease (True Positive rate). High sensitivity is crucial for screening tests to ensure few cases are missed. * **Specificity (Option B):** The ability of the test to correctly identify those without the disease (True Negative rate). High specificity minimizes "false alarms." 2. **Predictive Value (Option C):** While sensitivity and specificity are inherent properties of the test, **Predictive Values** determine the test's usefulness in a real-world clinical setting. * **Positive Predictive Value (PPV):** The probability that a person actually has the disease given a positive test result. * **Negative Predictive Value (NPV):** The probability that a person is healthy given a negative test result. ### **Why other options are incorrect** Options A, B, and C are all individual components of test evaluation. Selecting only one would be incomplete, as a test cannot be fully validated without assessing both its inherent accuracy (Sensitivity/Specificity) and its clinical applicability (Predictive Values). ### **High-Yield Clinical Pearls for NEET-PG** * **Prevalence Impact:** Sensitivity and Specificity are **independent** of disease prevalence. However, **Predictive Values are highly dependent** on prevalence. (As prevalence ↑, PPV ↑ and NPV ↓). * **Screening vs. Diagnosis:** Screening tests should be highly **sensitive** (to cast a wide net), while confirmatory/diagnostic tests should be highly **specific** (to rule out disease). * **Yield:** This refers to the amount of previously unrecognized disease diagnosed as a result of the screening effort. * **Likelihood Ratio:** Another high-yield evaluation tool; $LR+ = \text{Sensitivity} / (1 - \text{Specificity})$.

Question 233: What is the term for the presence of a causative agent without transmission?

A. Elimination (Correct Answer)
B. Control
C. Eradication
D. Holoendemic

Explanation: ### Explanation The correct answer is **Elimination**. **1. Why Elimination is Correct:** In epidemiology, **Elimination** refers to the interruption of transmission of a disease in a specific geographic area (e.g., a country or continent). While the causative agent (virus, bacteria, or parasite) may still exist in the environment or in a laboratory setting, the **chain of transmission** among the population has been broken. The incidence of the disease is reduced to zero in that defined area. * *Example:* Maternal and Neonatal Tetanus (MNT) has been eliminated from India, meaning transmission is interrupted, but the spores remain in the soil. **2. Why Other Options are Incorrect:** * **Control (B):** This refers to the reduction of disease incidence, prevalence, morbidity, or mortality to a locally acceptable level through deliberate efforts. Transmission still occurs, but at a lower rate. * **Eradication (C):** This is the "all or none" phenomenon. It implies the **permanent termination** of all transmission worldwide and the **extinction of the causative agent** in nature. Once a disease is eradicated, intervention measures are no longer needed. * *Only two diseases have been eradicated:* Smallpox (1980) and Rinderpest (2011). * **Holoendemic (D):** This describes a situation where a disease is prevalent in a population at a very high level, typically infecting nearly all children, while adults show less evidence of the disease due to acquired immunity (e.g., Malaria in some African regions). **3. High-Yield Clinical Pearls for NEET-PG:** * **Hierarchy of Disease Cessation:** Control → Elimination → Eradication → Extinction. * **Elimination vs. Eradication:** Elimination is geographic (local); Eradication is global. * **Target for Elimination:** For many diseases, the target is defined as <1 case per 10,000 or 1,000,000 population depending on the specific WHO criteria. * **Monitoring:** Surveillance must continue after elimination to prevent re-introduction, whereas it can eventually stop after eradication.

Question 234: What measure is estimated in a case-control study?

A. Odds ratio (Correct Answer)
B. Odds ratio and attributable risk
C. Relative risk, attributable risk, population attributable risk
D. Incidence, Relative risk, and attributable risk

Explanation: ### Explanation In epidemiology, the choice of study design dictates which measures of association can be calculated. **Why Option A is Correct:** A **Case-Control Study** is retrospective; it starts with the outcome (disease) and looks backward to determine exposure. Because the researcher determines the number of cases and controls, the true **Incidence** of the disease cannot be calculated. Without incidence, we cannot calculate Relative Risk (RR). Instead, we use the **Odds Ratio (OR)**, which estimates the strength of the association between exposure and outcome by comparing the odds of exposure among cases to the odds of exposure among controls. **Why Other Options are Incorrect:** * **Options C and D:** These include **Incidence, Relative Risk (RR), and Attributable Risk (AR)**. These measures require the calculation of incidence (new cases over time), which can only be directly measured in a **Cohort Study** (prospective design). * **Option B:** While it includes Odds Ratio, it also includes Attributable Risk. Attributable Risk requires incidence data from a cohort to determine how much of the disease is specifically due to the exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Case-Control Study:** Best for **rare diseases** or diseases with long latency periods. It is fast and inexpensive but prone to **recall bias**. * **Cohort Study:** Best for **rare exposures**. It can calculate Incidence, RR, AR, and PAR. * **Odds Ratio vs. Relative Risk:** OR is a good estimate of RR when the disease is rare (the "Rare Disease Assumption"). * **Formula for OR:** $(a/c) / (b/d)$ or simply $ad/bc$ (cross-product ratio).

Question 235: Which of the following best defines a pandemic?

A. An epidemic confined to a small population.
B. A disease that is constantly present in a large population.
C. An epidemic that has spread to a small region.
D. An epidemic that has spread over several countries or continents, affecting a large number of people. (Correct Answer)

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The term **Pandemic** (derived from Greek *pan* meaning "all" and *demos* meaning "people") refers to an epidemic that has crossed international boundaries and usually affects a large number of people on a worldwide scale. The defining characteristic is the **geographical extent** (multiple countries or continents) rather than the severity of the disease. For instance, COVID-19 and H1N1 Influenza are classic examples of pandemics. **2. Analysis of Incorrect Options:** * **Option A & C:** These describe a localized increase in cases. An epidemic confined to a small population or region is simply termed an **Epidemic** (or an **Outbreak** if it is very localized, like in a village or institution). * **Option B:** This describes an **Endemic** disease. Endemicity refers to the constant presence of a disease or infectious agent within a given geographic area or population group without external importation (e.g., Malaria in certain parts of India). **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Sporadic:** Scattered cases occurring irregularly, haphazardly, and infrequently (e.g., Tetanus). * **Epizootic:** An epidemic occurring in an animal population (e.g., Anthrax, Rabies). * **Enzootic:** An endemic disease in an animal population. * **Epornitic:** An epidemic occurring in a bird population (e.g., Avian Flu). * **Exotic:** A disease that is not normally present in a country but is introduced from abroad (e.g., Rabies in the UK). * **Key Distinction:** An epidemic is an occurrence of cases in **excess of normal expectancy**. Even a single case of a previously eliminated disease (like Polio) can be defined as an epidemic.

Question 236: Which of the following is a live attenuated vaccine?

A. Measles (Correct Answer)
B. Rabies
C. Hepatitis B
D. Typhoid

Explanation: **Explanation:** Live attenuated vaccines are prepared from wild viruses or bacteria that have been weakened (attenuated) in a laboratory. They replicate in the recipient to produce an immune response without causing the actual disease. 1. **Correct Answer: Measles (Option A):** The Measles vaccine (Edmonston-Zagreb strain) is a classic example of a live attenuated viral vaccine. It is typically administered at 9 months and 16–24 months under the Universal Immunization Programme (UIP). 2. **Incorrect Options:** * **Rabies (Option B):** This is a **killed/inactivated vaccine**. In India, the most common type is the Human Diploid Cell Vaccine (HDCV) or Purified Chick Embryo Cell Vaccine (PCECV). * **Hepatitis B (Option C):** This is a **recombinant/subunit vaccine** produced using yeast cells (*Saccharomyces cerevisiae*) containing the HBsAg gene. * **Typhoid (Option D):** While a live oral typhoid vaccine (Ty21a) exists, the standard injectable typhoid vaccine used in many programs is the **Vi polysaccharide** or **Typhoid Conjugate Vaccine (TCV)**, which are inactivated. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**BOY** **R**omeo **M**eets **V**ictoria **L**ately **I**n **T**hailand" (**B**CG, **O**PV, **Y**ellow Fever, **R**otavirus, **M**easles/MMR, **V**aricella, **L**ive **I**nfluenza, **T**yphoid Ty21a). * **Contraindication:** Live vaccines are generally contraindicated in pregnancy and immunocompromised states (except HIV patients before the symptomatic stage). * **Storage:** Most live vaccines are highly heat-sensitive and must be stored in the freezer compartment or at +2°C to +8°C.

Question 237: In which one of the following does the host factor show a bimodal incidence curve?

A. Kaposi's Sarcoma
B. Osteosarcoma
C. Hodgkin's lymphoma (Correct Answer)
D. Lung cancer

Explanation: **Explanation:** The correct answer is **Hodgkin’s Lymphoma (HL)**. In epidemiology, a **bimodal incidence curve** refers to a distribution where there are two distinct peaks of occurrence across different age groups. 1. **Why Hodgkin’s Lymphoma is correct:** HL classically exhibits two peaks in developed countries: * **First Peak:** Young adults (typically aged 15–34 years). * **Second Peak:** Older adults (typically aged 50 years and above). This pattern is thought to reflect different etiologies, such as a possible infectious trigger (like EBV) in younger patients versus age-related immune senescence or different genetic factors in the elderly. 2. **Analysis of Incorrect Options:** * **Kaposi’s Sarcoma:** Generally shows a linear or unimodal increase in incidence, particularly associated with HIV/AIDS status or elderly Mediterranean men, but does not follow a classic bimodal age distribution. * **Osteosarcoma:** While it has a major peak during the adolescent growth spurt, the secondary rise in the elderly (often associated with Paget’s disease) is less pronounced and not considered a classic "bimodal curve" in the same epidemiological context as HL. * **Lung Cancer:** Shows a **unimodal** distribution where the incidence increases steadily with age, peaking in the 6th or 7th decade of life, primarily due to cumulative exposure to carcinogens like tobacco smoke. **High-Yield Clinical Pearls for NEET-PG:** * **Other Bimodal Diseases:** Apart from HL, **Systemic Lupus Erythematosus (SLE)** and **Ulcerative Colitis** are often cited as having bimodal age distributions. * **HL Histology:** The presence of **Reed-Sternberg (RS) cells** ("Owl-eye appearance") is the pathognomonic feature. * **EBV Association:** The Mixed Cellularity subtype of HL has the strongest association with the Epstein-Barr Virus.

Question 238: The Aedes aegypti index should be less than what percentage?

A. 1% (Correct Answer)
B. 5%
C. 8%
D. 10%

Explanation: **Explanation:** The **Aedes aegypti index** (also known as the House Index) is a key entomological indicator used to monitor the risk of transmission for diseases like Dengue, Chikungunya, and Zika. It is defined as the percentage of houses found positive for Aedes aegypti larvae or pupae. **1. Why 1% is the correct answer:** According to World Health Organization (WHO) and National Vector Borne Disease Control Programme (NVBDCP) guidelines, an Aedes aegypti index of **less than 1%** is considered the "safety threshold." When the index is maintained below 1%, the risk of an epidemic outbreak is considered negligible. If the index rises above this level, it indicates a potential for disease transmission. **2. Analysis of Incorrect Options:** * **B (5%):** While a 5% threshold is sometimes used for the *Breteau Index* (number of positive containers per 100 houses) to indicate low risk, it is not the safety standard for the House Index. * **C & D (8% and 10%):** These values represent high-risk scenarios. An index exceeding 10% is often associated with a high probability of an explosive outbreak during the transmission season. **3. NEET-PG High-Yield Pearls:** * **House Index (HI):** (Houses positive / Houses inspected) × 100. * **Container Index (CI):** (Containers positive / Containers inspected) × 100. * **Breteau Index (BI):** (Number of positive containers / Total houses inspected) × 100. (Considered the best predictor of Aedes density). * **Aedes aegypti** is a "day biter," breeds in clean stagnant water (artificial containers), and exhibits "intermittent feeding" (biting multiple people to complete one blood meal), which increases its epidemic potential.

Question 239: The mass treatment of trachoma is undertaken if the prevalence in the community is:

A. 3%
B. 10%
C. 5% (Correct Answer)
D. 6%

Explanation: **Explanation:** The correct answer is **5%**. This threshold is based on the **WHO SAFE Strategy** for the elimination of blinding trachoma. **1. Why 5% is Correct:** According to WHO guidelines, mass drug administration (MDA) with antibiotics (usually oral Azithromycin) is indicated when the prevalence of **Trachomatous Inflammation—Follicular (TF)** in children aged 1–9 years is **5% or higher**. * If prevalence is **≥5%**, annual mass treatment is required for at least 3 years before re-surveying. * The goal is to reduce the community reservoir of *Chlamydia trachomatis* to levels where transmission is no longer sustainable. **2. Why Other Options are Incorrect:** * **3% (Option A):** This is below the intervention threshold. At this level, the disease is monitored, but mass treatment is not considered cost-effective or epidemiologically necessary. * **10% (Option D):** Previously, 10% was a significant benchmark for more intensive annual treatment. However, the current WHO recommendation for initiating MDA starts at the lower threshold of **5%** to ensure elimination. * **6% (Option D):** While 6% would technically trigger mass treatment (as it is >5%), it is not the standard "cutoff" value defined in public health guidelines. **3. High-Yield Clinical Pearls for NEET-PG:** * **SAFE Strategy:** **S**urgery (for trichiasis), **A**ntibiotics (MDA), **F**acial cleanliness, **E**nvironmental improvement. * **Drug of Choice:** A single dose of **Azithromycin (20 mg/kg)** is the mainstay of mass treatment. Tetracycline eye ointment (1%) is an alternative. * **Target Population:** For MDA, the prevalence is specifically measured in children aged **1–9 years**, as they are the primary reservoir of infection. * **Elimination Goal:** India has been declared free from "infective trachoma," but surveillance continues to prevent recurrence.

Question 240: Which of the following does not determine specific protection?

A. Pap smear for early detection of carcinoma cervix in the community (Correct Answer)
B. Wearing of goggles by welders
C. Wearing of seat belts by car drivers
D. Vitamin A supplementation for children's prophylaxis

Explanation: ### Explanation The core of this question lies in understanding the **Levels of Prevention** and their associated **Modes of Intervention**. **1. Why Option A is the Correct Answer:** A **Pap smear** is a screening tool used for the **early detection** of cervical cancer in asymptomatic individuals. According to Leavell and Clark’s levels of prevention, "Early Diagnosis and Treatment" constitutes **Secondary Prevention**. Specific protection, on the other hand, is a mode of intervention under **Primary Prevention**. Therefore, a Pap smear does not determine specific protection. **2. Analysis of Incorrect Options (Why they represent Specific Protection):** Specific protection refers to measures taken to intercept the cause of a disease before it involves the human host. * **Option B (Goggles for welders):** This is a form of personal protective equipment (PPE) used to prevent a specific occupational hazard (photokeratitis/arc eye). * **Option C (Seat belts):** This is a specific safety measure designed to prevent or reduce the severity of injury during a motor vehicle accident. * **Option D (Vitamin A supplementation):** This is a specific nutritional intervention aimed at preventing xerophthalmia and nutritional blindness in a high-risk group (children). **3. NEET-PG High-Yield Pearls:** * **Primordial Prevention:** Action taken to prevent the emergence of risk factors (e.g., discouraging children from starting smoking). * **Primary Prevention (Specific Protection):** Includes immunizations, chemoprophylaxis, use of specific nutrients, and protection against occupational hazards. * **Secondary Prevention:** Focuses on "Early Diagnosis and Treatment" (e.g., all screening tests like Pap smears, Sputum AFB, or Mammography). * **Tertiary Prevention:** Includes "Disability Limitation" and "Rehabilitation."

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free